Influence of the genotype on the clinical course of the long-QT syndrome

New England Journal of Medicine

Volumn 339, Issue 14, 1998, Pages 960-965

  Zareba, Wojciech ^a,k   Moss, Arthur J ^a   Schwartz, Peter J ^b,c   Vincent, G Michael ^d   Robinson, Jennifer L ^a   Priori, Silvia G ^e   Benhorin, Jesaia ^g   Locati, Emanuela H ^a,f   Towbin, Jeffrey A ^h   Keating, Mark T ⁱ   Lehmann, Michael H ^j   Hall, W Jackson ^a   Andrews, Mark L ^a   Napolitano, Carlo ^b   Timothy, Katherine ^d   Zhang, Li ^d   Medina, Aharon ^g   MacCluer, Jean W ^l  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d LDS HOSPITAL   (United States)

^e IRCCS   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

^g BIKUR CHOLIM HOSPITAL   (Israel)

^h TEXAS CHILDREN S HOSPITAL   (United States)

ⁱ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^j Sinai Hospital   (United States)

^k UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^l SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DISEASE COURSE; FEMALE; GENE LOCUS; GENOTYPE; HEART RATE; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEART ARREST; HUMANS; LONG QT SYNDROME; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SYNCOPE;

EID: 0032189139     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199810013391404     Document Type: Article

References (29)

1. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957;54:59-68.
2. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell'eta' pediatrica. II. Accessi sincopali per fibrillazione ventricolare parossistica. Clin Pediatr 1963;45:656-61.
3. Ward OC. New familial cardiac syndrome in children. J Ir Med Assoc 1964;103-6.
4. Schwartz PJ, Periti M, Malliani A. The long Q-T syndrome. Am Heart J 1975;89:378-90.
5. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991;84:1136-44.
6. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation 1993;88:782-4.
7. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996;12:17-23.
8. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995;80:795-803.
9. Wang Q, Shen J, Splawski I, et al. SCN5A mutations cause an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-11.
10. Ks cardiac potassium current. Nature 1996;384:78-80.
11. Ks function. Nat Genet 1997;17:338-40.
12. Schott JJ, Charpentier F, Peltier S, et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995;57:1114-22.
13. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-34.
14. Hajj Ali R, Zareba W, Rosero SZ, et al. Adrenergic triggers and non-adrenergic factors associated with cardiac events in long QT syndrome patients. Pacing Clin Electrophysiol 1997;20:1072. abstract.
15. Schwartz PJ, Matteo PS, Moss AJ, et al. Gene-specific influence on the triggers for cardiac arrest in long QT syndrome. Circulation 1997;96:Suppl 1:1-212. abstract.
16. Kr. Nature 1997;388:289-92.
17. Bazett HC. An analysis of time-relations of electrocardiograms. Heart 1920;7:353-70.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
20. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 1992;327:846-52.
21. Lehmann MH, Timothy KW, Frankovich D, et al. Age-gender influence on rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol 1997;29:93-9.
22. Zareba W, Moss AJ, le Cessie S, et al. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol 1995;26: 1685-91.
23. Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 1996;94:1471-4.
24. +-channel messenger RNA in rat myometrium during oestrus cycle and in pregnancy. Nature 1987;330:373-5.
25. Shimizu W, Antzelevitch C. Characteristics of spontaneous as well as stimulation-induced torsade de pointes in LQT2 and LQT3 models of the long QT syndrome. Circulation 1997;96:Suppl I:I-554. abstract.
26. el-Sherif N, Caref EB, Yin H, Restivo M. The elcctrophysiological mechanism of ventricular arrhythmias in the long QT syndrome: tridimensional mapping of activation and recovery patterns. Circ Res 1996;79:474-92.
27. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 as well as LQT3 models of the long-QT syndrome. Circulation 1997;96:2038-47.
28. + channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation 1995;92:3381-6.
29. Rosero SZ, Zareba W, Robinson JL, Moss AJ. Gene-specific therapy for long QT syndrome: QT shortening with lidocaine and tocainide in patients with mutation of the sodium-channel gene. Ann Noninvasive Electrocardiol 1997;2:274-8.